CNS Pharmaceuticals Inc. (CNSP) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    CNS Pharmaceuticals Inc.

    NASDAQ: CNSP · Real-Time Price · USD
    9.39
    0.44 (4.86%)
    At close: Oct 06, 2025, 3:34 PM

    CNS Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.54 -12.58K -10.66K -61.54K
    PEG Ratio
    		 0.04 226.95 -5.28 8.77K
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 3.71 -53.51K 20.01K 134.7K
    P/FCF Ratio
    		 -1.34 -16.77K -15.41K -65.86K
    P/OCF Ratio
    		 -1.34 -16.77K -15.42K -65.89K
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.05 -0.07 0.05 0.06
    Quick Ratio
    		 3.43 0.26 2.55 2.88
    Current Ratio
    		 3.43 0.26 2.55 2.88
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 -924.5 -1.37K -2.17K -1.56K
    Return on Equity
    		 -2.41 4.25 -1.88 -2.19
    Return on Assets
    		 -1.71 -11.08 -1.17 -1.66
    Return on Invested Capital
    		 -2.29 4.57 -1.79 -2.21
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist